Both in Pharmaceuticals
Omeros vs Oric Pharmaceuticals
Over the past year OMER returned +360.5% and ORIC returned +15.1%; their daily moves had a correlation of 0.05.
OMER +360.5% ORIC +15.1%Growth of $1, one year, split-adjusted
| Metric | OMER | ORIC |
|---|---|---|
| Price | $19.25 | $13.37 |
| Market cap | $1.39B | $1.39B |
| Today | −0.93% | +0.75% |
| 1 month | +3.4% | +1.0% |
| 6 months | +96.2% | +9.7% |
| Year to date | +12.1% | +63.4% |
| 1 year | +331.6% | +20.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 97.2% | — |
| Net margin | 46.4% | — |
| P/E (TTM) | 11.2× | — |
| Price / sales | 36.3× | — |
| Net cash | $58.7M | $264.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.0% | 69.4% |
| Short % of float | 19.5% | 27.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).